March 26, 2018
Article
The vaccine reduced the risk of herpes zoster by 68.2% in high-risk recipients of hematopoietic stem cell transplant.
FDA Lifts Clinical Hold of Lenacapavir for HIV Treatment and Prevention
First In-Africa Clinical Trial of mRNA HIV Vaccine
Fourth COVID-19 Vaccine Dose Boosts Immunity Above Third Shot
Estrogen Treatment Reduces Risk of COVID-19 Mortality